MONTREAL, December 11, 2025--(BUSINESS WIRE)--Neurenati Therapeutics, a biotech company focused on the development of therapies for rare diseases, is pleased to appoint two highly-experienced members ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results